Journal of Hepatology
Volume 50, Issue 4 , Pages 664-673 , April 2009

Who should get a liver graft?

  • Richard B. Freeman

      Affiliations

    • Division of Transplantation, Box 40, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 617 636 5592; fax: +1 617 636 8228.
    • ,
  • Neville Jamieson

      Affiliations

    • Department of Surgery, Addenbrooke’s Hospital, Cambridge University Hospitals, Cambridge, UK
    • ,
  • Douglas E. Schaubel

      Affiliations

    • Department of Biostatistics, University of Michigan, Ann Arbor, USA
    • ,
  • Robert J. Porte

      Affiliations

    • Department of Hepatobiliary Surgery and Liver Transplantation, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    • ,
  • Federico G. Villamil

      Affiliations

    • Liver Unit, Favaloro Foundation and University, Buenos Aires, Argentina

References 

  1. Neuberger J, James O. Guidelines for selection of patients for liver transplantation in the era of donor-organ shortage. Lancet. 1999;354:1636–1639
  2. Neuberger J, Gimson A, Davies M, Akyol M, O’Grady J, Burroughs A, et al. Liver Advisory Group; UK blood and transplant. Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut. 2008;57:252–257
  3. Organ Donation Taskforce. Organs for transplants. A report from the Organ Donation Taskforce. Department of Health, Crown Publications; 2008.
  4. Freeman RB. MELD: the holy grail of organ allocation?. J Hepatol. 2005;42:16–20
  5. Freeman RB. The model for end-stage liver disease comes of age. Clin Liver Dis. 2007;11:249–263
  6. Freeman RB, Harper A, Edwards EB. Excellent liver transplant survival rates under the MELD/PELD system. Transpl Proc. 2005;37:585–588
  7. Volk ML, Lok AS, Pelletier SJ, Ubel PA, Hayward RA. Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation. Gastroenterology. 2008;135:1568–1574
  8. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transpl. 2005;5:307–313
  9. Freeman RB. Utility is not just posttransplant outcome!. Am J Transpl. 2006;6:2817
  10. Schaubel DE, Wolfe RA, Sima CS, Merion RM. Estimating the effect of a time-dependent treatment by levels of an internal time-dependent covariate. J Am Stat Assoc, in press.
  11. Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transpl. 2008;8:419–425
  12. Berg CL, Gillespie BW, Merion RM, Brown RS, Abecassis MM, Trotter JF, et al. A2ALL Study Group. Improvement in survival associated with adult-to-adult living donor liver transplantation.. Gastroenterology. 2007;133:1806–1813
  13. Merion RM, Ashby VB, Wolfe RA, Distant DA, Hulbert-Shearon TE, Metzger RA, et al. Deceased-donor characteristics and the survival benefit of kidney transplantation. J Am Med Assoc. 2005;294:2726–2733
  14. Egan TM, Murray S, Bustami RT, Shearon TH, McCullough KP, Edwards LB, et al. Development of the new lung allocation system in the United States. Am J Transpl. 2006;6:1212–1227
  15. Wolfe RA, McCullough KP, Schaubel DE, Kalbfleisch JD, Murray S, Stegall MD, et al. Calculating lifeyears from transplant (LYFT): methods for kidney and kidney-pancreas candidates. Am J Transpl. 2008;8:997–1011
  16. Schaubel DE, Guidinger MK, Biggins SW, Kalbfleisch JD, Pomfret EA, Sharma P, et al. Survival benefit-based deceased-donor liver allocation. Am J Transpl, in press.
  17. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864–871
  18. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–470
  19. Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl. 2001;7:567–580
  20. Sharma P, Schaubel DE, Sima CS, Merion RM, Lok ASF. Re-weighting the model for end-stage liver disease score components. Gastroenterology. 2008;135:1575–1581
  21. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130:1652–1660
  22. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359:1018–1026
  23. Burra P, Porte RJ. Should donors and recipients be matched in liver transplantation?. J Hepatol. 2006;45:488–494
  24. Müllhaupt B, Dimitroulis D, Gerlach JT, Clavien PA. Hot topics in liver transplantation: organ allocation – extended criteria donor – living donor liver transplantation. J Hepatol. 2008;48:S58–S67
  25. Mittler J, Pascher A, Neuhaus P, Pratschke J. The utility of extended criteria donor organs in severely ill liver transplant recipients. Transplantation. 2008;86:895–896
  26. Cameron AM, Ghobrial RM, Yersiz H, Farmer DG, Lipshutz GS, Gordon SA, et al. Optimal utilization of donor grafts with extended criteria. A single-center experience in over 1000 liver transplants. Ann Surg. 2006;243:748–755
  27. Cameron A, Busuttil R. AASLD/ILTS transplant course: is there an extended donor suitable for everyone?. Liver Transpl. 2005;11(Suppl. 1):S2–S5
  28. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transpl. 2006;6:783–790
  29. Durand F, Renz JF, Alkofer B, Burra P, Clavien PA, Porte RJ, et al. Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl. 2008;14:1694–1707
  30. Attia M, Silva MA, Mirza DF. The marginal liver donor – an update. Transpl Int. 2008;21:713
  31. Hashimoto K, Miller C. The use of marginal grafts in liver transplantation. J Hepatobiliary Pancreat Surg. 2008;15:92–101
  32. Briceno J, Padillo J, Rufián S, Solórzano G, Pera C. Assignment of steatotic livers by the Mayo model for end-stage liver disease. Transpl Int. 2005;18:577–583
  33. Amin MG, Wolf MP, TenBrook JA, Freeman RB, Cheng SJ, Pratt DS, et al. Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl. 2004;10:1468–1475
  34. McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Clavien PA. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg. 2007;246:940–946
  35. Briceno J, Ciria R, Pleguezuelo M, de la Mata M, Muntané J, Naranjo A, et al. Impact of donor graft steatosis on overall ouycome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis. Liver Transpl. 2009;15:37–48
  36. Majella Doyle MB, Anderson CD, Vachharajani N, Lowell JA, Shenoy S, Lisker-Melman M, et al. Liver transplantation for hepatitis C. Effect of using older donor grafts on short- and medium-term survival. Arch Surg. 2008;143:679–685
  37. Freeman RB, Weisner RH, Harper A, McDairmid SV, Lake J, Edwards EB, et al. The new liver allocation system: moving towards evidence-based transplantation policy. Liver Transpl. 2002;8:851–858
  38. Wiesner RH, Freeman RB, Mulligan DC. Liver transplant for hepatocelluar carcinoma: the impact of the MELD allocation policy. Gastroenterology. 2004;127(5 Suppl. 1):S261–S267
  39. Wiesner R, Lake JR, Freeman RB, Gish RG. Model for end stage liver disease (MELD) exception guidelines. Liver Transpl. 2006;12(Suppl. 3):S85–S87
  40. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–699
  41. Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transpl. 2007;7:2587–2596
  42. Iwatsuki S, Dvorchik I, Marsh JW, Madariaga JR, Carr B, Fung JJ, et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 2000;191:389–394
  43. Piscaglia F, Camaggi V, Ravaioli M, Grazi GL, Zanello M, Leoni S, et al. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. Liver Transpl. 2007;13:857–866
  44. Freeman RB, Edwards EB, Harper AM. Waiting list removal rates among patients with chronic and malignant liver diseases. Am J Transpl. 2006;6:1416–1421
  45. Freeman RB, Steffick DE, Guidinger MK, Farmer DG, Berg CL, Merion RM. Liver and intestine transplantation in the United States, 1997–2006. Am J Transpl. 2008;8:958–976
  46. Otto G, Herber S, Heise M, Lohse AW, Monch C, Bittinger F, et al. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl. 2006;12:1260–1267
  47. Yao FY, Hirose R, LaBerge JM, Davern TJ, Bass NM, Kerlan RK, et al. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl. 2005;11:1505–1514
  48. Ichai P, Samuel D. Etiology and prognosis of fulminant hepatitis in adults. Liver Transpl. 2008;14:S67–S79
  49. Lee WM, Squires RH, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: summary of a workshop. Hepatology. 2008;47:1401–1415
  50. O’Grady JG, Graeme JM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–445
  51. Yantorno SE, Kremers WK, Ruf AE, Trentadue JJ, Podesta LG, Villamil FG. MELD is superior to King’s College and Clichy’s criteria to assess prognosis in fulminant hepatic failure. Liver Transpl. 2007;13:822–828
  52. Kremers WK, Van Ijperen M, Kim WR, Freeman RB, Harper AM, Kamath PS, et al. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology. 2004;39:764–769
  53. Bernuau J, Goudeau A, Poynard T, Dubois F, Lesage F, Yvonnet B, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology. 1986;6:648–651
  54. Yantorno SE, Kremers WK, Ruf AE, Trentadue JJ, Andriani OC, Podesta LG, et al. MELD is superior to the King’s college and Clichy’s criteria irrespective of the clinical variants or etiology of fulminant hepatic failure. Liver Transpl. 2005;11:C-1;(A1)
  55. Katoonizadeh A, Decaestecker J, Wilmer A, Aerts R, Verslype C, Vansteenbergen W, et al. MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure. Liver Int. 2007;27:329–334
  56. Dhiman RK, Jain S, Maheshwari U, Bhalla A, Sharma N, Ahluwalia J, et al. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King’s College Hospital criteria. Liver Transpl. 2007;13:814–821
  57. Zhou L, Dong P-L, Ding H-G. Comparison scoring model of severe viral hepatitis and model of end stage liver disease for the prognosis of patients with liver failure in China. World J Gastroenterol. 2007;13:2999–3002
  58. Pelaez-Luna M, Martinez-Salgado J, Olivera-Martinez MA. Utility of the Mayo end-stage liver disease score, King’s college criteria and a new in-hospital mortality score in the prognosis of in-hospital mortality in acute liver failure. Transpl Proc. 2006;38:927–929
  59. O’Grady JG, Schalm SW, Willliams R. Acute liver failure: redefining the syndromes. Lancet. 1993;342:273–275
  60. Section 121.8, Federal Register, [FR Doc. 98-8191] 42 CFR Part 121 April 2, 1998.

☆ The authors declare that they do not have anything to disclose regarding funding from industries or conflict of interest with respect to this manuscript. NIH funded study (R01 DK-70869).

PII: S0168-8278(09)00073-7

doi: 10.1016/j.jhep.2009.01.013

Journal of Hepatology
Volume 50, Issue 4 , Pages 664-673 , April 2009

Article Tools

* Image Usage & Resolution